An interventional study of genetic analysis and genetic assay in Schizophrenia, Schizoaffective Disorder and Bipolar Disorder, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-18.
Sponsored by Northwestern University · Not applicable, Interventional, and Diagnostic
The goals of this study are to replicate previous findings of genetic predictors of response to clozapine and other antipsychotic drugs.
3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.
This study's enrollment of 37 is below the median of 70 across 2,872 interventional studies indexed under Schizophrenia.
Browse Schizophrenia studies →Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.
Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients with the diagnoses of schizophrenia or schizoaffective disorder, and bipolar disorder or major depression with psychotic features, or volunteers with no history of a psychotic disorder.
Exclusion Criteria:
Patients with DSM-IV diagnoses other than schizophrenia or schizoaffective disorder, and bipolar disorder or major depression with psychotic features.
clozapine
Procedure: genetic analysis · Procedure: genetic assay
Other Antipsychotics
Procedure: genetic analysis · Procedure: genetic assay
genetic assay of blood sample drawn with patient's consent
genetic assay of blood sample drawn with patient's consent
We plan to compare the polymorphisms across schizophrenic patients and adults who do not have a diagnosed major mental illness. .
Time frame: single visit
We will also evaluate relationships between the polymorphism and past and current mental health among the non-diagnosed sample
Time frame: single visit
This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Northwestern University